Edition:
India

Brainstorm Cell Therapuetics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.56USD
19 Jan 2018
Change (% chg)

-- (--)
Prev Close
$3.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
15,961
52-wk High
$5.15
52-wk Low
$2.57

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
FY 2016 Dec '16 0.00 -0.033
Sep '16 0.00 -0.086
Jun '16 0.00 -0.052
Mar '16 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.32 -0.32 -0.32 --
Quarter Ending Jun-18 1 -0.28 -0.28 -0.28 --
Year Ending Dec-18 1 -1.18 -1.18 -1.18 -1.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapuetics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.77%
# of Holders: 42
Total Shares Held: 1,651,882
3 Mo. Net Change: 11,195
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 0
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.